1 Updates
Asthma drug that cures severe itchy rash
Photo Credit: Spencer Platt, Getty Images

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a...

Filed under: news

Full Story below YouTube Videos

 
 

 

1 year ago

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Known as omalizumab, the drug was tested on 323 people at 55 medical centres for whom standard antihistamine therapy failed to quell underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

"Physicians and patients may now have a fast, safe and well-tolerated treatment option to consider before prescribing even more antihistamines, which can be highly sedating," says Sarbjit (Romi) Saini, Johns Hopkins allergist and immunologist, and study co-investigator, the The New England Journal of Medicine reports.

The study, from 2009 to 2011, involved mostly women aged between 12 and 75 years. Each was randomly assigned to take one of three dosing regimens of omalizumab, or placebo, after which they were monitored through regular checkups for four months, according to a Johns Hopkins statement.

All of them had chronic hives (itchy bumps on the skin) and rash for at least six months, with many having suffered from the condition for more than five years.

"Patients suffering with this condition need more and better treatment options because chronic hives and rash are profoundly hard to treat and can be very debilitating," says Saini, associate professor at the Johns Hopkins University School of Medicine.

Saini, who has studied omalizumab since 2005, points out that fewer than half of those treated respond to traditional drug treatments with antihistamines. Saini says the new study results offer substantial evidence that this first injection treatment option not only works, but does so more safely than other drugs.

These findings were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas.

IANS

Source: IANS

 

Don't miss ...

 

<a href="/latest_stories/all/all/8" rel="author">Luigi Lugmayr</a>
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.

 

blog comments powered by Disqus

Latest stories

Samsung Has Purchased New Patents Just For Court
Samsung Has Purchased New Patents Just For Court
According to Apple, Samsung purchased patents just so they could sue Apple
 
 
Apple Hard At Work On Siri For Apple TV
Apple Hard At Work On Siri For Apple TV
Apple continues working to improve Apple TV use
 
 
The iWatch May Kill Off The iPod
The iWatch May Kill Off The iPod
Wall Street expects that the iPod sales have stalled ahead of iWatch’s release
 
 
Apple's iPad Rules The Enterprise. So When's The Second Act?
Apple's iPad is a fixture in the enterprise market, the company is proud to say. During the investor call for its second quarterly earnings Apple CEO Tim Cook noted–as he has in previous earnings calls–that 98% of the...
 
 
 

Latest from the Network

Boogeymen and shady deals define spin for Senate
WASHINGTON (AP) — The fight for the Senate majority boils down to boogeyman billionaires against the shifty septuagenarian — if party operatives' spin is to be believed. For months, Senate Majority Leader...
Read more on Business Balla
 
Samsung Has Purchased New Patents Just For Court
As the court battle between Apple and Samsung continues, there are even more revelations coming out, showing what lengths the companies are willing to go to. Currently, that involves Samsung purchasing patents wight he...
Read more on Apple Balla
 
Apple Hard At Work On Siri For Apple TV
Apple TV has been one of the products that has disappointed many in the long run. That might be about to change, though, since Apple is going to be working on several new features, one of which we have gotten a look at...
Read more on Apple Balla
 
The iWatch May Kill Off The iPod
Apple is set to release their sales numbers for Q2 and many analysts are now expecting iPod sales to have stalled almost entirely, prompting new expectations for the iWatch that might finally see a release later this...
Read more on Apple Balla
 
FCC to propose pay-for-priority Internet standards
LOS ANGELES (AP) — The Federal Communications Commission is set to propose new open Internet rules that would allow content companies to pay for faster delivery over the so-called "last mile" connection to people's...
Read more on Business Balla
 
Debra Messing has lost 20 pounds
Debra Messing feels great after losing 20 pounds. The former 'Will and Grace' star - who split from Daniel Zelman in June 2012 after 10 years of marriage, with whom she has 10-year-old son Roman - claims she didn't mean...
Read more on Celebrity Balla
 
Apple's iPad Rules The Enterprise. So When's The Second Act?
Apple's iPad is a fixture in the enterprise market, the company is proud to say. During the investor call for its second quarterly earnings Apple CEO Tim Cook noted–as he has in previous earnings calls–that 98% of the...
Read more on Apple Balla
 
Zynga founder Pincus leaving operations role
NEW YORK (AP) — Online game maker Zynga's founder Mark Pincus is stepping down as chief product officer, less than a year after he was replaced as the company's CEO, as the company's sales slide. Zynga...
Read more on Business Balla
 
Courteney Cox sparks engagement rumors
Courteney Cox has sparked rumors she is engaged to Johnny McDaid. The former 'Friends' actress, who started dating the Snow Patrol frontman in September, was spotted wearing a huge diamond ring on her engagement finger...
Read more on Celebrity Balla
 
Reports On The Death Of The iPad Are Greatly Exaggerated
Apple’s second quarter results were announced today by CEO Tim Cook (Mark Rogowsky has more coverage here on Forbes). As part of the earnings call, Cook talked about the sales and acceptance of the iPad. Sales are lower...
Read more on Apple Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla